Neutralizing antibodies and pathogenesis of hepatitis C virus infection.
about
Capitalizing on knowledge of hepatitis C virus neutralizing epitopes for rational vaccine designSynthetic anti-lipopolysaccharide peptides and hepatitis C virus infection.Structural and antigenic definition of hepatitis C virus E2 glycoprotein epitopes targeted by monoclonal antibodies.Identification of a novel epitope in the C terminus of hepatitis C virus-E2 protein that induces potent and cross-reactive neutralizing antibodies.Functional Analysis of Hepatitis C Virus (HCV) Envelope Protein E1 Using a trans-Complementation System Reveals a Dual Role of a Putative Fusion Peptide of E1 in both HCV Entry and Morphogenesis.New insights into HCV replication in original cells from Aedes mosquitoes.Effective epitope identification employing phylogenetic, mutational variability, sequence entropy, and correlated mutation analysis targeting NS5B protein of hepatitis C virus: from bioinformatics to therapeutics.Clinical Evaluation of Terap C Vaccine in Combined Treatment with Interferon and Ribavirin in Patients with Hepatitis C.CD4+ T Cell Differentiation in Chronic Viral Infections: The Tfh Perspective.
P2860
Q30374314-58DC1165-B691-4560-A205-3527E35F58E9Q38103293-B13B75AF-AD04-4494-84AE-F789E8002E54Q38128299-799C61D8-BE90-45F3-8C97-D3E3A3D7BE66Q38715557-29BCDE21-5BE4-45B3-A18E-F40CD4DF8E15Q38720669-5DDC4F23-39A0-4153-8724-2DD5E5F6EA9DQ40074972-4C474307-1142-4195-9C69-C9E101ABC31BQ41332304-DFF90539-1A59-4CC8-A33F-444DEA501ACBQ47108259-F610DCFC-0F70-4CA2-82BC-23BC28E42F8CQ47580241-8AFF1934-CBC6-4F33-99BD-2002C27806C9
P2860
Neutralizing antibodies and pathogenesis of hepatitis C virus infection.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Neutralizing antibodies and pathogenesis of hepatitis C virus infection.
@ast
Neutralizing antibodies and pathogenesis of hepatitis C virus infection.
@en
type
label
Neutralizing antibodies and pathogenesis of hepatitis C virus infection.
@ast
Neutralizing antibodies and pathogenesis of hepatitis C virus infection.
@en
prefLabel
Neutralizing antibodies and pathogenesis of hepatitis C virus infection.
@ast
Neutralizing antibodies and pathogenesis of hepatitis C virus infection.
@en
P2093
P2860
P921
P356
P1433
P1476
Neutralizing antibodies and pathogenesis of hepatitis C virus infection.
@en
P2093
Catherine Fauvelle
Françoise Stoll-Keller
Isabel Fofana
Laura Heydmann
Mirjam B Zeisel
Quentin Lepiller
Samira Fafi-Kremer
Thomas F Baumert
P2860
P304
P356
10.3390/V4102016
P577
2012-10-09T00:00:00Z